Deutsche Bank’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,278
| Closed | -$179K | – | 4049 |
|
|
2022
Q4 | $179K | Sell |
8,278
-41,010
| -83% | -$867K | ﹤0.01% | 3035 |
|
|
2022
Q3 | $954K | Sell |
49,288
-1,144
| -2% | -$23.7K | ﹤0.01% | 2003 |
|
|
2022
Q2 | $1M | Buy |
50,432
+40,845
| +426% | +$1.08M | ﹤0.01% | 2183 |
|
|
2022
Q1 | $286K | Sell |
9,587
-1,080
| -10% | -$31.6K | ﹤0.01% | 3060 |
|
|
2021
Q4 | $248K | Sell |
10,667
-16,807
| -61% | -$447K | ﹤0.01% | 3272 |
|
|
2021
Q3 | $857K | Sell |
27,474
-311
| -1% | -$9.62K | ﹤0.01% | 2718 |
|
|
2021
Q2 | $977K | Sell |
27,785
-844
| -3% | -$27.4K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $1.01M | Sell |
28,629
-1,023
| -3% | -$37.8K | ﹤0.01% | 2653 |
|
|
2020
Q4 | $1.11M | Sell |
29,652
-73,587
| -71% | -$2.68M | ﹤0.01% | 2368 |
|
|
2020
Q3 | $3.44M | Sell |
103,239
-13,987
| -12% | -$407K | ﹤0.01% | 1434 |
|
|
2020
Q2 | $3.1M | Buy |
117,226
+59,334
| +102% | +$1.4M | ﹤0.01% | 1545 |
|
|
2020
Q1 | $947K | Buy |
57,892
+42,643
| +280% | +$938K | ﹤0.01% | 2112 |
|
|
2019
Q4 | $386K | Sell |
15,249
-17,405
| -53% | -$348K | ﹤0.01% | 2857 |
|
|
2019
Q3 | $650K | Buy |
32,654
+6,507
| +25% | +$168K | ﹤0.01% | 2554 |
|
|
2019
Q2 | $841K | Buy |
26,147
+14,761
| +130% | +$494K | ﹤0.01% | 2955 |
|
|
2019
Q1 | $365K | Sell |
11,386
-524
| -4% | -$14.1K | ﹤0.01% | 3641 |
|
|
2018
Q4 | $291K | Sell |
11,910
-8,746
| -42% | -$231K | ﹤0.01% | 3663 |
|
|
2018
Q3 | $680K | Sell |
20,656
-2,260
| -10% | -$73.9K | ﹤0.01% | 3579 |
|
|
2018
Q2 | $813K | Buy |
22,916
+22,816
| +22,816% | +$739K | ﹤0.01% | 3578 |
|
|
2018
Q1 | $3K | Buy |
+100
| New | +$3.37K | ﹤0.01% | 5291 |
|
|
2017
Q4 | – | Sell |
-68,060
| Closed | -$1.43M | – | 5209 |
|
|
2017
Q3 | $1.43M | Buy |
68,060
+65,660
| +2,736% | +$1.57M | ﹤0.01% | 2779 |
|
|
2017
Q2 | $49K | Buy |
+2,400
| New | +$49.2K | ﹤0.01% | 4384 |
|
|
2017
Q1 | – | Sell |
-1,246
| Closed | -$21K | – | 5169 |
|
|
2016
Q4 | $21K | Buy |
+1,246
| New | +$25.9K | ﹤0.01% | 4580 |
|
|
2016
Q3 | – | Sell |
-26
| Closed | – | – | 5295 |
|
|
2016
Q2 | $0 | Sell |
26
-6,877
| -100% | -$75.8K | ﹤0.01% | 5403 |
|
|
2016
Q1 | $68K | Buy |
6,903
+5,297
| +330% | +$47.1K | ﹤0.01% | 4204 |
|
|
2015
Q4 | $16K | Sell |
1,606
-884
| -36% | -$9.14K | ﹤0.01% | 4822 |
|
|
2015
Q3 | $32K | Hold |
2,490
| – | – | ﹤0.01% | 4620 |
|
|
2015
Q2 | $76K | Buy |
2,490
+1,372
| +123% | +$46.1K | ﹤0.01% | 4380 |
|
|
2015
Q1 | $39K | Buy |
1,118
+182
| +19% | +$7.67K | ﹤0.01% | 4466 |
|
|
2014
Q4 | $37K | Buy |
+936
| New | +$41.1K | ﹤0.01% | 5282 |
|
|
2014
Q2 | – | Sell |
-2
| Closed | – | – | 6128 |
|
|
2014
Q1 | $0 | Buy |
+2
| New | +$182 | ﹤0.01% | 5843 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5779 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5791 |
|
Other funds holding ALBO
Deutsche Bank's ALBO Position: Q1 2023 in Review
Deutsche Bank sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 8,278 shares — an estimated $179K sold.
Deutsche Bank first reported a position in ALBO in Q1 2014 and held it in 31 quarters. The position peaked at $3.44M in Q3 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Deutsche Bank reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Deutsche Bank sold 8,278 Albireo Pharma Inc shares in Q1 2023, an estimated $179K.
- Deutsche Bank first reported a position in Albireo Pharma Inc in Q1 2014 and held it in 31 quarters.
- Deutsche Bank's Albireo Pharma Inc position peaked at $3.44M in Q3 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.